Skip to main content

mNEXSPIKE News

Moderna's New Lower-Dose COVID-19 Vaccine Approved by FDA

TUESDAY, June 3, 2025 – The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus...

FDA Approves mNEXSPIKE (COVID-19 Vaccine, mRNA) to Prevent COVID-19

CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283), a new vaccine agai...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

COVID-19

mNEXSPIKE patient information at Drugs.com